These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 396393

  • 1. Adsorption of Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K, Iida H, Sugiyama H.
    Jpn J Med Sci Biol; 1979 Apr; 32(2):125-6. PubMed ID: 396393
    [No Abstract] [Full Text] [Related]

  • 2. Adsorption to Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K, Sugiyama H.
    Proc Soc Exp Biol Med; 1978 Oct; 159(1):61-4. PubMed ID: 362423
    [No Abstract] [Full Text] [Related]

  • 3. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Iida H, Oguma K, Inoue K.
    Jpn J Med Sci Biol; 1974 Apr; 27(2):101-3. PubMed ID: 4601039
    [No Abstract] [Full Text] [Related]

  • 4. High and low toxin production by a non-toxigenic strain of Clostridium botulinum type C following infection with type C phages of different passage history.
    Oguma K, Iida H.
    J Gen Microbiol; 1979 May; 112(1):203-6. PubMed ID: 383896
    [Abstract] [Full Text] [Related]

  • 5. Bacteriophages and Toxigencity in Clostridium Botulinum types C and D.
    Oguma K, Iida H, Inove K.
    Schweiz Med Wochenschr; 1975 Dec 20; 105(51):548-52. PubMed ID: 766180
    [No Abstract] [Full Text] [Related]

  • 6. C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin.
    Nakamura S, Serikawa T, Yamakawa K, Nishida S, Kozaki S, Sakaguchi G.
    Jpn J Med Sci Biol; 1979 Apr 20; 32(2):128-9. PubMed ID: 396395
    [No Abstract] [Full Text] [Related]

  • 7. Phage-conversion of toxigenicity in Clostridium botulinum types C and D.
    Inoue K, Iida H.
    Jpn J Med Sci Biol; 1971 Feb 20; 24(1):53-6. PubMed ID: 4931809
    [No Abstract] [Full Text] [Related]

  • 8. [Toxigenicity and bacteriophages of Clostridium botulinum].
    Oguma K.
    Nihon Saikingaku Zasshi; 1974 Jul 20; 29(4):665-9. PubMed ID: 4613878
    [No Abstract] [Full Text] [Related]

  • 9. [Production of the trypsin-activable toxin by Clostridium botulinum type C and D strains (author's transl)].
    Nakane A.
    Nihon Saikingaku Zasshi; 1977 Nov 20; 32(6):805-11. PubMed ID: 342740
    [No Abstract] [Full Text] [Related]

  • 10. [Toxin production and phage in Clostridium botulinum].
    Iida H.
    Nihon Saikingaku Zasshi; 1985 Sep 20; 40(5):827-34. PubMed ID: 3908743
    [No Abstract] [Full Text] [Related]

  • 11. [Toxigenicity and bacteriophage in Clostridium botulinum (author's transl)].
    Iida H.
    Tanpakushitsu Kakusan Koso; 1976 Nov 20; Suppl():31-44. PubMed ID: 800280
    [No Abstract] [Full Text] [Related]

  • 12. [Ultrastructure of Clostridium botulinum type E during the process of toxin formation].
    Lysenko AI, Cherniavskiĭ VI, Kulakova GS, Iskritskiĭ GV.
    Mikrobiol Zh; 1973 Nov 20; 35(3):308-12. PubMed ID: 4598684
    [No Abstract] [Full Text] [Related]

  • 13. Production of trypsin-activable toxic components by Clostridium botulinum types C and D [proceedings].
    Nakane A, Oguma K, Shiozaki M, Iida H.
    Jpn J Med Sci Biol; 1978 Apr 20; 31(2):166-9. PubMed ID: 355684
    [No Abstract] [Full Text] [Related]

  • 14. Bacteriophage and toxigenicity in Clostridium botulinum: an additional evidence for phage conversion.
    Oguma K, Iida H, Inoue K.
    Jpn J Microbiol; 1973 Sep 20; 17(5):425-6. PubMed ID: 4587764
    [No Abstract] [Full Text] [Related]

  • 15. The origin, structure, and pharmacological activity of botulinum toxin.
    Simpson LL.
    Pharmacol Rev; 1981 Sep 20; 33(3):155-88. PubMed ID: 6119708
    [No Abstract] [Full Text] [Related]

  • 16. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW, Poysky FT.
    Appl Microbiol; 1974 Jan 20; 27(1):251-8. PubMed ID: 4589131
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of broiler chickens to Clostridium botulinum type C toxin.
    Dohms JE, Cloud SS.
    Avian Dis; 1982 Jan 20; 26(1):89-96. PubMed ID: 7046722
    [Abstract] [Full Text] [Related]

  • 18. Identification of structural genes for Clostridium botulinum type C neurotoxin-converting phage particles.
    Hwang HJ, Lee JC, Yamamoto Y, Sarker MR, Tsuchiya T, Oguma K.
    FEMS Microbiol Lett; 2007 May 20; 270(1):82-9. PubMed ID: 17302935
    [Abstract] [Full Text] [Related]

  • 19. The taxonomic position of Clostridium botulinum type c.
    Jansen BC, Knoetze PC.
    Onderstepoort J Vet Res; 1977 Jun 20; 44(2):53-4. PubMed ID: 351507
    [Abstract] [Full Text] [Related]

  • 20. [Phage conversion of toxigenicity in Clostridium botulinum].
    Khotenko SG, Perova EV, Golikov VI, Bulatova TI, Il'iashenko BN.
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug 20; (8):25-8. PubMed ID: 7004020
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.